Closed System Transfer Devices Market Report 2025

This Closed System Transfer Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The closed system transfer devices market size has grown rapidly in recent years. It will grow from $1.04 billion in 2024 to $1.19 billion in 2025 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increased oncology drug approvals, rise in focus on occupational safety, rise in need to curb needlestick injuries and exposure to hazardous drugs, increased awareness about potential dangers of cytotoxic drug exposure, growth in chemotherapy patient population.

The closed system transfer devices market size is expected to see rapid growth in the next few years. It will grow to $2.03 billion in 2029 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to increasing occurrence of cancer, increasing need for monitoring compliance for safe management of injurious drugs, growing awareness regarding usage of closed system transfer devices, rising implementation of CSTDS for transporting hazardous medications, escalating quantity of drug sanctions for cancer. Major trends in the forecast period include new product launches and safety, development of digital platforms and user-friendly devices, high research and development activity, technological advancements, adoption of membrane-to-membrane systems.

The rising incidence of cancer is expected to drive the growth of the closed-system transfer devices market in the coming years. Cancer is a disease characterized by the uncontrolled growth of abnormal cells, which can invade nearby tissues and spread through the blood and lymph systems to other parts of the body. The prevalence of cancer is increasing due to various factors, including lifestyle choices, environmental exposures, and higher rates of infections. Closed-system transfer devices are crucial in cancer treatment as they help protect healthcare workers and patients from the dangers associated with handling and administering chemotherapy drugs. These devices contribute to a safer healthcare environment and improve treatment outcomes for cancer patients. For example, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, projected in February 2024 that by 2050, global cancer cases will surpass 35 million, marking a 77% increase from the 20 million cases expected in 2022. This significant rise underscores the growing cancer burden worldwide. Additionally, the National Center for Biotechnology Information (NCBI), a US-based intergovernmental organization, reported in January 2023 that there were 1,958,310 new cancer cases in the United States, with 609,820 cancer-related deaths projected for 2023. Therefore, the increasing number of cancer cases is driving the demand for closed-system transfer devices.

Leading companies in the closed-system transfer devices (CSTD) market are focusing on developing innovative syringe units to enhance safety, improve user experience, reduce contamination risks, and ensure compliance with strict regulatory standards in the healthcare industry. A syringe unit designed for full-volume use is meant to deliver the entire volume of a liquid or medication without the need for additional mixing or dilution. For example, in October 2023, Equashield, a US-based medical device company, introduced the EQUASHIELD Syringe Unit, which received FDA clearance for full-volume use. This design ensures safer and more efficient handling of hazardous drugs by preventing vapor escape and plunger contamination, providing a cost-effective solution for compounding and administering medications.

In January 2022, ICU Medical, Inc., a US-based company specializing in medical products for infusion therapy and critical care, acquired Smiths Medical, Inc. for an undisclosed amount. This acquisition allows ICU Medical to strengthen its presence in the closed system transfer devices market by integrating Smiths Medical’s advanced infusion, syringe, and ambulatory devices into its portfolio. As a result, ICU Medical can expand its product offerings and enhance its safety-focused solutions for the secure transfer of hazardous drugs. Smiths Medical, also based in the US, manufactures closed system transfer devices and safety devices.

Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., Corning Incorporated, B Braun Melsungen AG, Grifols SA, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Carmel Pharma AB, Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical.

North America was the largest region in the closed system transfer device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the closed system transfer devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Closed system transfer devices (CSTDs) are specialized tools used for transferring drugs while mechanically preventing environmental contaminants from entering and hazardous drugs or vapors from escaping. They establish a closed, leak-proof system to ensure the safe handling of hazardous substances in healthcare settings.

There are two main types of closed-system transfer devices, needleless systems and membrane-to-membrane systems. The latter refers to a lipid membrane model commonly employed in scientific research to study biological membrane characteristics and dynamics. These devices utilize various technologies such as diaphragm-based, compartmentalized, and filtration mechanisms, often integrated with closing mechanisms such as color-to-color alignment, push-to-turn, click-to-lock, and luer-lock systems. They are utilized by diverse end-users including hospitals, clinics, oncology centers, and other healthcare facilities.

The closed system transfer devices market research report is one of a series of new reports that provides closed system transfer devices market statistics, including closed system transfer devices industry global market size, regional shares, competitors with a closed system transfer devices market share, detailed closed system transfer devices market segments, market trends, and opportunities, and any further data you may need to thrive in the closed system transfer devices industry. This closed system transfer devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The closed system transfer devices market consists of sales of closed vial access devices (CVADs), closed syringe transfer systems, closed bag systems, and closed ampoule systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.